![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
Menin Inhibitors 101 with Dr. Joshua Zeidner
Menin Inhibitors 101 with Dr. Joshua Zeidner
Event Description
What are menin inhibitors? How are they used in AML care? Listen to this pre-recorded podcast episode to hear Dr. Joshua Zeidner, an AML expert and lead researcher in menin inhibitors, answer these questions and more by sharing data from one of his recent studies.
Schedule & Agenda
Mary Arnett interviews Dr. Joshua Zeidner on all things menin inhibitors and Dr. Zeidner's recent study.
Mary Arnett interviews Dr. Joshua Zeidner on all things menin inhibitors and Dr. Zeidner's recent study.
Speakers & Moderators
Mary joined HealthTree in 2022 as a part of HealthTree's team to help expand into all blood cancers. She now works as HealthTree's Volunteer & Community Outreach Manager, helping to engage and involve community members in HealthTree's mission. When she isn't working, she loves being the fun aunt to her 13 nieces and nephews, attending concerts, experimenting with new recipes in the kitchen, and traveling to explore new cities.
Dr. Zeidner specializes in the management of patients with acute leukemia, MDS, and MPNs. His research focuses on developing innovative methods to improve clinical outcomes in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Dr. Zeidner is the Chief of the Leukemia Research Program at the University of North Carolina.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org
Get the Latest Myelofibrosis Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.
Together we care.
Together we cure.